Figure S7 from The TOPK Inhibitor HI-TOPK-032 Enhances CAR T-cell Therapy of Hepatocellular Carcinoma by Upregulating Memory T Cells
Year: 2024
Type: other
Abstract: Continuous treatment with HI-TOPK-032 increases the expression of effector molecules but reduces some of the exhaustion molecules in CAR-T cells in vitro.
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4396599449
